Stevens-Johnson syndrome (SJS) is an acute inflammatory eruption of the skin and mucous membranes. Presented here is a case of an 18-month-old child admitted to the hospital with raised erythematous rash with some vesicular formation. The rash and associated symptomatology developed in a manner consistent with SJS. The child was treated for 27 days and was discharged in a much improved condition. This syndrome is reviewed in regard to incidence, etiology, clinical features, and management. Of particular emphasis are the drugs that may precipitate this syndrome.
Von HebraF. On diseases of the skin including the exanthemata (translated by FaggeCH). London: New Sydenham Society1866; 1: 285–9.
2.
StevensAMJohnsonFC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child1922; 24: 526–33.
3.
EdmondBJHuffJCWestonWL. Erythema multiforme. In: RasmussenJE, ed. The pediatric clinics of North America, Symposium on Pediatric Dermatology II. Philadelphia: WB Saunders, 1983: 631–40.
4.
HuffJCWestonELTonnesenMG. Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol1983; 8: 763–75.
5.
ThomasBA. The so-called Stevens-Johnson syndrome. Br Med J1950; 1: 1393–7.
6.
MagaliniS, Stevens-Johnson: Dictionary of medical syndromes. Philadelphia: JB Lippincott, 1971: 493–4.
7.
MoschellaSLPillsburyDMHurleyHJ. Hypersensitivity and miscellaneous inflammatory disorders. In: Dermatologyvol I. Philadelphia: WB Saunders, 1975: 387–90.
VirantFSReddingGJNovackAH. Multiple pulmonary complications in a patient with Stevens-Johnson syndrome. Clin Pediatr (Phila)1984; 23: 412–4.
14.
FoyHMKennyGHKolerJ. Mycoplasma pneumoniae in Stevens-Johnson syndrome. Lancet1966; 2: 550–1.
15.
LundlamGBBridgesJBBennEC. Association with Stevens-Johnson syndrome with antibody for. Lancet1964; 1: 958–9.
16.
LyellAGordonAMDickHM. Mycoplasma and erythema multiforme. Lancet1967; 2: 1116–8.
17.
SandersDYJohnsonHW. Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infection. Am J Dis Child1971; 121: 243–5.
18.
DeLARochaSRLeonardJCDemetriouE. Potential permanent respiratory sequela of Stevens-Johnson syndrome in an adolescent. J Adolesc Health Care1985; 6: 220–3.
19.
BianchineJRMacaraegPVJLasagnaL. Drugs or etiologic factors in the Stevens-Johnson syndrome. Am J Med1968; 44: 390–405.
20.
BigbyMSternR. Cutaneous reactions to nonsteroidal anti-inflammatory drugs. A review. J Am Acad Dermatol1985; 12: 866–76.
21.
KauppinenKStubbS. Drug eruptions: Causative agents and clinical types. A series of in-patients during a 10-year period. Acta Derm Venereol (Stockh)1984; 64: 320–4.
22.
GenvertOICohenEJDonnenfeldEDBlecherMH. Erythema multiforme after use of topical sulfacetamide. Am J Ophthalmol1985; 99: 465–8.
AdzickNSKimSHBondocCCQuinbyWCRemensnyderJP. Management of toxic epidermal necrolysis in a pediatric burn center. Am J Dis Child1985; 139: 499–502.
25.
ChanHL. Observations on drug-induced toxic epidermal necrolysis in Singapore. J Am Acad Dermatol1984; 10: 973–8.
26.
WrightPCollinJR. The ocular complications of erythema multiforme (Stevens-Johnson syndrome) and their management. Trans Ophthalmol Soc UK1983; 103: 338–41.
